ليست عنوان مقالات لاتين Anger and hostility in adolescents: Relationships with self-reported attachment style and perceived parental rearing styles Angular distribution of leptons in general tt̄ production and decay

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Anger and hostility in adolescents: Relationships with self-reported attachment style and perceived parental rearing styles

2

Anger and hostility in maritally violent men: Conceptual distinctions, measurement issues, and literature review

3

Anger and hostility linked to coronary heart disease

4

Anger and impulsivity in non-clinical women

5

Anger and inhibitory control as moderators of childrenʹs hostile attributions and aggression

6

Anger and inhibitory control as moderators of childrenʹs hostile attributions and aggression

7

Anger and Irritability Symptoms among Youth with ODD: Cross-Informant Versus Source-Exclusive Syndromes

8

Anger and personality in eating disorders

9

Anger and psychopathology in prison inmates

10

Anger and somatization

11

Anger and the behavioral approach system

12

Anger as a cue to truthfulness

13

Anger as a Psychological Risk Factor of Hypertension

14

Anger assessment with the STAXI-CA: psychometric properties of a new instrument for children and adolescents

15

Anger at graphic evidence at Omagh inquest

16

Anger at US transplant waiting times “scare”

17

Anger Attacks in Major Depressive Disorder and Serum Levels of Homocysteine

18

Anger expression and essential hypertension: Behavioral response to confrontation

19

Anger expression in children and adolescents: A review of the empirical literature

20

Anger expression in Swiss adolescents: Establishing measurement invariance across gender in the AX scales

21

Anger expression, coping, and substance use in adolescent offenders

22

Anger expression, partner support, and quality of life in cancer patients

23

Anger in Adolescent Boy Athletes: a Comparison among Judo, Karate, Swimming and Non Athletes

24

Anger in chronic pain: Investigations of anger targets and intensity

25

Anger in healthy men: a PET study using script-driven imagery

26

Anger in prisoners: women are different from men

27

Anger in the Trajectory of Healing From Childhood Maltreatment

28

Anger in UK as discredited doctor is elected to doctorsʹ ruling body

29

Anger induced by interferon-alpha is moderated by ratio of arachidonic acid to omega-3 fatty acids

30

Anger Management among Medical Undergraduate Students and Its Impact on Their Mental Health and Curricular Activities

31

Anger Management and Control in Social and Behavioral Sciences: A Systematic Review of Literature on Biopyschosocial Model

32

Anger Management and Factors that Influence Anger in Physicians

33

Anger Management May Save Your Life: New Insights Into Emotional Precipitants of Ventricular Arrhythmias

34

Anger management style and the prediction of treatment outcome among male and female chronic pain patients

35

Anger on ruling not to prosecute Irish doctors

36

Anger over dangerous withdrawal of antipsychotics from Pakistan

37

Anger over handling of Madagascarʹs cholera epidemic

38

Anger response styles and reaction to provocation

39

Anger rumination in Hong Kong and Great Britain: Validation of the scale and a cross-cultural comparison

40

Anger scale and anger types of patients with fifth metacarpal neck fracture

41

Anger scale and anger types of patients with fifth metacarpal neck fracture

42

Anger superiority effect for change detection and change blindness

43

Anger suppression mediates the relationship between optimism and natural killer cell cytotoxicity in men treated for localized prostate cancer

44

Anger symptoms and “delinquent” behavior in Tourette syndrome with and without attention deficit hyperactivity disorder

45

Anger types and the use of cigarettes and smokeless tobacco among Native American adolescents

46

Anger, aggression, and risky behavior: a comparison of high and low anger drivers

47

Anger, aggression, risky behavior, and crash-related outcomes in three groups of drivers

48

Anger, Anger Expression, and Suicidal Ideation in Korean Adolescents

49

Anger, Depression, and Anxiety in Cardiac Patients: The Complexity of Individual Differences in Psychological Risk

50

Anger, depression, and coping interactions in headache activity and adjustment: a controlled study

51

Anger, hostility, and male perpetrators of intimate partner violence: A meta-analytic review

52

Anger, negative emotions, and cardiovascular reactivity during interpersonal conflict in women

53

Anger, over-control and serious violent offending

54

Anger, psychopathology and cognitive inhibition: a study of UK servicemen

55

Anger, Suppressed Anger, and Risk of Adverse Events in Patients With Coronary Artery Disease

56

Anger-associated panic attacks in Cambodian refugees with PTSD; a multiple baseline examination of clinical data

57

Anger-in and hostility in myocardial infarction patients

58

Anger-Induced T-Wave Alternans Predicts Future Ventricular Arrhythmias in Patients With Implantable Cardioverter-Defibrillators

59

Angerlike behavioral state potentiates myocardial ischemia-induced T-wave alternans in canines

60

Anggaran dan Ciri Fizikokimia Sisa Buangan Makanan di Bandar Baru Bangi

61

angian lattice boltzmann method for euler equati

62

Angina 1 year after percutaneous coronary intervention: A report from the NHLBI Dynamic Registry

63

Angina and origin of three major coronary arteries from independent ostia in right coronary sinus

64

Angina and sudden cardiac death caused by anomalous right coronary artery origin from above the left coronary cusp

65

Angina bullosa hemorrhagica: an idiopathic intraoral blistering disorder

66

Angina caused by coronary steal phenomenon

67

Angina caused by systolic compression of the left coronary artery as a result of pseudoaneurysm of the mitral-aortic intervalvular fibrosa

68

Angina for 14 years

69

Angina Pectoris and Atherosclerotic Risk Factors in the Multisite Cardiac Lifestyle Intervention Program

70

Angina pectoris and myocardial infarction with the use of leuprolife acetate

71

Angina pectoris caused by coronary microvascular spasm

72

Angina pectoris caused by microvascular spasm

73

Angina pectoris caused by microvascular spasm

74

Angina Pectoris or Myocardial Infarctions, Pulmonary Arteriovenous Malformations, Hereditary Hemorrhagic Telangiectasia, and Paradoxical Emboli

75

Angina pectoris prior to myocardial infarction protects against subsequent left ventricular remodeling Original Research Article

76

Angina pectoris: a headache

77

Angina reassessed: pain or protector?

78

Angina Self-Management Plan and Quality of Life, Anxiety and Depression in Post Coronary Angioplasty Patients

79

Angina symptoms in men and women with stable coronary artery disease and evidence of exercise-induced myocardial perfusion defects

80

Angina-Induced Protection Against Myocardial Infarction in Adult and Elderly Patients: Loss of Preconditioning Mechanism in the Aging Heart?

81

Anginal Status and Prediction of Cardiac Events in Patients Enrolled in the Asymptomatic Cardiac Ischemia Pilot (ACIP) Study

82

Anginal symptoms consistently predict total mortality among outpatients with coronary artery disease

83

Angioarchitecture and blood circulation in focal nodular hyperplasia of the liver

84

Angioarchitecture of monochorionic placentas in relation to the twin-twin transfusion syndrome

85

Angioarrestin mRNA expression in early-stage lung cancers

86

Angio-Associated Migratory Cell Protein and Smooth Muscle Cell Migration in Development of Restenosis and Atherosclerosis

87

Angioblasts in peripheral blood

88

Angiocardiographic findings in patients with biphasic T-wave inversion in precordial leads

89

Angiocardiography and magnetic resonance imaging to assess pulmonary regurgitation in repaired tetralogy of Fallot

90

Angiocentric Nasal T-Cell Lymphoma in a Patient with Idiopathic CD4+ Lymphocytopenia

91

Angiodysplasia: New Look at an Old Conundrum

92

Angiodysplastic lesions as a cause of colonic bleeding in patients with chronic renal disease: is there an association?

93

Angioedema and urticaria as early presentations of a COVID-19 patient: a case report

94

Angioedema Associated With Droperidol Administration, , ,

95

Angioedema Associated with Haloperidol

96

Angioedema associated with sumatriptan administration

97

Angioedema due to acquired C1-inhibitor deficiency: A bridging condition between autoimmunity and lymphoproliferation

98

Angioedema Due to Lamiaceae Allergy

99

Angioedema Due to Lamiaceae Allergy

100

Angioedema in a Patient with C1 Esterase Inhibitor Deficiency

101

Angioedema related to the ue of hyaluronidae in cataract urgery

102

Angioedema. Interdisciplinary diagnostic and therapeutic recommendations of the Polish Dermatological Society (PTD) and Polish Society of Allergology (PTA)

103

Angioembolization as an effective alternative for hemostasis in intractable life-threatening maxillofacial trauma hemorrhage: case study

104

Angioembolization in itractable epistaxis — a tertiary care experience

105

Angioemboliziation of Internal Pudendal Artery for Treatment of Long Lasting Gross Hematuria After Transurethral Resection of the Prostate

106

Angiofibroma of the Nasal Septum

107

Angiofollicular lymph node hyperplasia (Castlemanʹs disease)

108

Angiogenèse et radiothérapie : tout ce qu’un oncologue radiothérapeute doit savoir

109

Angiogenesis and anti-angiogenesis in hepatocellular carcinoma

110

Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma

111

Angiogenesis and breast cancer

112

Angiogenesis and breast cancer metastasis

113

Angiogenesis and chronic disease

114

Angiogenesis and functional recovery demonstrated after minor stroke

115

Angiogenesis and growth factor expression in a model of transmyocardial revascularization

116

Angiogenesis and growth factor modulation induced by alternagin C, a snake venom disintegrin-like, cysteine-rich protein on a rat skin wound model

117

Angiogenesis and hepatocellular carcinoma

118

Angiogenesis and intrauterine growth restriction

119

Angiogenesis and Its Targeting in Glioblastoma with Focus on Clinical Approaches

120

Angiogenesis and Mast Cells Density in Oral and Esophageal Squamous Cell Carcinomas

121

Angiogenesis and Minimal Residual Disease in Patients with Acute Myeloid Leukemia

122

Angiogenesis and molecular biologic substaging in patients with stage I non—small cell lung cancer

123

Angiogenesis and Morphometry of Bovine Placentas in Late Gestation from Embryos Produced In Vivo or In Vitro

124

Angiogenesis and musculogenesis as two facets of inflammatory post-ischemic tissue regeneration

125

Angiogenesis and Nitric Oxide in Elderly Men after Continuous and Interval Aerobic Training

126

Angiogenesis and placental growth in normal and compromised pregnancies

127

Angiogenesis and Tumor-Associated Macrophages in Different Grades of Oral Squamous Cell Carcinoma, Verrucous Carcinoma and Epithelial Dysplasia via Immunohistochemical Assessment of Expression of CD34 and CD68 Markers

128

Angiogenesis and vascular endothelial growth factor expression in the equine corpus luteum

129

Angiogenesis as targeted breast cancer therapy

130

Angiogenesis assays

131

ANGIOGENESIS EFFECTS OF CHINESE HERBAL SALVIA MILTIORRHIZA AFTER ACUTE MYOCARDIAL INFARCTION IN RATS

132

Angiogenesis factor in endometrial carcinoma: A new prognostic indicator?, ,

133

Angiogenesis Following Three-Dimensional Culture of Isolated Human Endometrial Stromal Cells

134

Angiogenesis Following Three-Dimensional Culture of Isolated Human Endometrial Stromal Cells

135

Angiogenesis in bone fracture healing: A bioregulatory model

136

Angiogenesis in cervical intraepithelial neoplasia and the risk of recurrence, ,

137

Angiogenesis in chronic myelogenous leukaemia

138

Angiogenesis in chronic myelogenous leukaemia

139

Angiogenesis in colon hyperplastic polyp

140

Angiogenesis in ductal breast carcinoma and its correlation with the prognostic parameters

141

Angiogenesis in ductal breast carcinoma. Comparison of microvessel density between primary tumour and lymph node metastasis

142

Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation

143

Angiogenesis in ischemic human myocardium: clinical results after 3 years

144

Angiogenesis in Ischemic Stroke Patients Aged 30 - 80 years at Gatot Subroto Army Central Hospital (RSPAD) Jakarta

145

Angiogenesis in neovascularized free muscle grafts

146

Angiogenesis in odontogenic keratocyst and dentigerous cyst: Evaluation of JunB and VEGF expression

147

ANGIOGENESIS IN OPEN TIBIAL FRACTURES: A COMPARISON OF MUSCLE AND FASCIOCUTANEOUS FLAPS

148

Angiogenesis in ovarian cancer

149

Angiogenesis in ovarian follicular and luteal development

150

Angiogenesis in primary and metastatic epithelial ovarian carcinoma, ,

151

Angiogenesis in Rat Ischemic Hindlimb: Role of Human Bone Marrow-Derived Mesenchymal Stem Cells Transplantation

152

Angiogenesis in the Pathobiology and Treatment of Vascular and Malignant Diseases

153

ANGIOGENESIS IN TISSUE ENGINEERING

154

Angiogenesis in transmyocardial revascularization: comparison of laser versus mechanical punctures

155

Angiogenesis induced by autologous whole bone marrow stem cells seeded on collagen scaffolds in silicone nerve tubes. An experimental study

156

Angiogenesis induced by urothelial cells (HCV-29) and their v-ras and v-raf transfectants

157

Angiogenesis inhibition plus chemotherapy for metastatic hormone refractory prostate cancer: History and rationale

158

Angiogenesis inhibitor DC101 delays growth of intracerebral glioblastoma but induces morbidity when combined with irradiation

159

Angiogenesis inhibitor TX-1898: syntheses of the enantiomers of sterically diverse haloacetylcarbamoyl-2-nitroimidazole hypoxic cell radiosensitizers Original Research Article

160

Angiogenesis inhibitors derived from thalidomide

161

Angiogenesis Is Enhanced in Ischemic Canine Myocardium by Transmyocardial Laser Revascularization

162

Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destruction

163

Angiogenesis modulatory activity of SC-CO2 leaf extract of guyabano (Annona muricata Linn.) using chick embryo chorioallantoic membrane assay

164

Angiogenesis of the ovary,

165

Angiogenesis Status in Patients with Acute Myeloid Leukemia: From Diagnosis to Post-hematopoietic Stem Cell Transplantation

166

Angiogenesis with recombinant fibroblast growth factor-2 for claudication

167

Angiogenesis with recombinant fibroblast growth factor-2 for claudication

168

ANGIOGENESIS WITHIN ATHEROSCLEROTIC LESIONS BY STEM/PROGENITOR CELLS

169

Angiogenesis, Arteriogenesis, and Diabetes: Paradigm Reassessed?

170

Angiogenesis, myogenesis and cell therapy I

171

Angiogenesis, Myogenesis, and Cell Therapies

172

Angiogenesis, tumor necrosis factor-α and procoagulant factors in coronary artery giant aneurysm of a fatal infantile Kawasaki disease

173

Angiogenesis/myogenesis cell therapy

174

Angiogenesis/myogenesis/cell therapy II

175

Angiogenesis: A Critical Role in Locally Aggressive Behavior of Keratocystic Odontogenic Tumor

176

Angiogenic activitiy of syndecan-binding laminin peptide AG73 (RKRLQVQLSIRT)

177

Angiogenic activity in the sera of patients with post-kidney transplant erythrocytosis

178

Angiogenic and inflammatory response to biodegradable scaffolds in dorsal skinfold chambers of mice

179

Angiogenic Effect of Leptin in the Quail Chorioallantoic Membrane

180

Angiogenic effect of naive and 5-fluorouracil resistant colon carcinoma on endothelial cells in vitro

181

Angiogenic effect of prostaglandin I 2 in relation with its effect on PPAR nuclear receptors

182

Angiogenic effect of the aqueous extract of Cynodon dactylon on human umbilical vein endothelial cells and granulation tissue in rat

183

ANGIOGENIC EFFECTS OF A NEW HMG-COA REDUCTASE INHIBITOR, PITAVASTATIN

184

Angiogenic Effects of Aerobic Training and Royal Jelly Consumption with Emphasis on the Role of miR-126 and miR-210 in the Aortic Artery of Ovariectomized Diabetic Rats

185

Angiogenic factors and the risk of preeclampsia: A systematic review and meta-analysis

186

Angiogenic factors in chronic liver diseases: the effects on hepatic progenitor cells

187

Angiogenic gene therapy with adenovirus 5 fibroblast growth factor-4 (Ad5FGF-4): a new option for the treatment of coronary artery disease

188

Angiogenic growth factors in human dentine matrix

189

Angiogenic growth factors released in human dental pulp following orthodontic force

190

Angiogenic induction and cell migration in an orthopaedically expanded maxillary suture in the rat

191

Angiogenic output in viral hepatitis, C and B, and HCV-associated hepatocellular carcinoma

192

Angiogenic response induced by acellular femoral matrix in vivo

193

Angiogenic responses are enhanced in mechanically and microscopically characterized, microbial transglutaminase crosslinked collagen matrices with increased stiffness

194

Angiogenic signal triggered by ischemic stress induces myocardial repair in rat during chronic infarction

195

Angiogenic therapy of acute myocardial infarction by intrapericardial injection of basic fibroblast growth factor and heparin sulfate: An experimental study

196

Angiogenin and osteopontin and coronary collateral circulation

197

Angiogenin plasma levels during pregnancy

198

Angiogenin: A marker for preterm delivery in midtrimester amniotic fluid, , , ,

199

Angiograph image restoration with the use of rule base fuzzy 2D Kalman filter

200

Angiographic 5-year follow-up study of right gastroepiploic artery grafts

201

Angiographic Adverse Events, Creatine Kinase-MB Elevation, and Ischemic End Points Complicating Percutaneous Coronary Intervention (a REPLACE-2 Substudy)

202

Angiographic Analysis of Pattern of Late Luminal Loss in Sirolimus- and Paclitaxel-Eluting Stents

203

Angiographic Analysis of the Anatomic Relation of Coronary Arteries to Mitral and Tricuspid Annulus and Implications for Radiofrequency Ablation

204

Angiographic analysis of the angioplasty versus rotational atherectomy for the treatment of diffuse in-stent restenosis trial (ARTIST)

205

Angiographic anatomical variation of origin of left circumflex coronary artery in Basrah

206

Angiographic anatomy of the grafted left internal mammary artery

207

Angiographic and clinical characteristics associated with increased in-hospital mortality in elderly patients with acute myocardial infarction undergoing percutaneous intervention (a pooled analysis of the primary angioplasty in myocardial infarction tria

208

Angiographic and clinical characteristics associated with the development of q-wave and non-q–wave myocardial infarction in the thrombolysis in myocardial infarction (timi) 14 trial

209

Angiographic and clinical outcome following coronary stenting of small vessels : comparison with coronary stenting of large vessels

210

Angiographic and clinical outcome of mild to moderate nonocclusive unstented coronary artery dissection and the influence on coronary flow velocity reserve

211

Angiographic and clinical outcomes associated with direct versus conventional stenting among patients treated with fibrinolytic therapy for ST-elevation acute myocardial infarction

212

Angiographic and clinical outcomes following acute infarct angioplasty on saphenous vein grafts

213

Angiographic and clinical outcomes of late total occlusion versus treatment failure without late total occlusion in patients after intracoronary radiation therapy for in-stent restenosis

214

Angiographic and clinical outcomes of polytetrafluoroethylene-covered stent use in significant coronary perforations

215

Angiographic and Interventional Radiological Management of Obscure Overt Gastrointestinal Bleeding

216

Angiographic and intravascular ultrasound predictors of in-stent restenosis

217

Angiographic and intravascular ultrasound study of the effects of overlapping sirolimus- and paclitaxel-eluting stents: Comparison with same drug-eluting overlapping stents

218

Angiographic and Magnetic Resonance Imaging Evaluation of In-Hospital Delay in Primary Percutaneous Intervention Delivery on Myocardial Salvage

219

Angiographic and morphologic features of the left ventricle in Ebsteinʹs malformation

220

Angiographic and procedural outcome after coronary angioplasty in high-risk subsets using a decremental diameter (tapered) balloon catheter

221

Angiographic and prognostic implications of an exaggerated exercise systolic blood pressure response and rest systolic blood pressure in adults undergoing evaluation for suspected coronary artery disease

222

Angiographic and three-dimensional intravascular ultrasound analysis of combined intracoronary beta radiation and self-expanding stent implantation in human coronary arteries

223

Angiographic and volumetric intravascular ultrasound comparison between direct Sirolimus-Eluting stent implantation versus predilation

224

Angiographic aspects of ruptured plaque in patients with acute myocardial infarction: correlation with clinical and laboratory variables

225

Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients

226

Angiographic assessment of myocardial perfusion in patients with isolated coronary artery ectasia

227

Angiographic changes in saphenous vein grafts are predictors of clinical outcomes

228

Angiographic changes in vein grafts: Stable surrogate or seductive siren?

229

Angiographic Characteristics of Coronary Disease and Postresuscitation Electrocardiograms in Patients With Aborted Cardiac Arrest Outside a Hospital

230

Angiographic characteristics of infarct-related and non-infarct-related stenoses in patients in whom stable angina progressed to acute myocardial infarction, ,

231

Angiographic complications in CADASIL

232

Angiographic complications of primary angioplasty

233

Angiographic coronary artery disease associated with hypertensive heart failure and normal ejection fraction. Insights from a prospective monocenter study

234

Angiographic correlates of “spotty” coronary artery calcium detected by electron-beam computed tomography in patients with normal or near-normal coronary angiograms

235

Angiographic correlates of cardiac death and myocardial infarction complicating major nonthoracic vascular surgery

236

Angiographic Correlates of Graft Patency and Relationship to Clinical Outcomes

237

Angiographic correlates of lesion relevance and suitability for percutaneous transluminal coronary angioplasty and coronary artery bypass grafting in the bypass angioplasty revascularization investigation study (BARI)

238

Angiographic deterioration of target coronary artery narrowing as a result of percutaneous balloon angioplasty, ,

239

Angiographic embolization for arrest of bleeding after penetrating trauma to the abdomen

240

Angiographic Embolization of a Traumatic Pulmonary Pseudoaneurysm

241

Angiographic Evaluation of Myocardial Perfusion in Patients With Syndrome X

242

Angiographic evaluation of the effect of intracoronary abciximab administration in patients undergoing urgent PCI

243

Angiographic evaluation of traumatic arterial injuries of the upper limbs: a retrospective study

244

Angiographic Evolution of Intracoronary Thrombus and Dissection Following Percutaneous Transluminal Coronary Angioplasty (The Thrombolysis and Angioplasty in Unstable Angina [TAUSA] Trial)

245

Angiographic Fate of Collateral Vessels After Surgical Revascularization of the Totally Occluded Left Anterior Descending Artery

246

Angiographic Features and Cardiovascular Risk Factors in Human Immunodeficiency Virus-Infected Patients With First-Time Acute Coronary Syndrome

247

Angiographic features of vein grafts versus ungrafted coronary arteries in patients with unstable angin and previous bypass surgery

248

Angiographic features, surgical management and outcomes of proximal middle cerebral artery aneurysms

249

Angiographic findings and clinical correlates in patients with cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry

250

Angiographic Findings and Outcome in Diabetic Patients Treated With Thrombolytic Therapy for Acute Myocardial Infarction: The GUSTO-I Experience

251

ANGIOGRAPHIC FINDINGS IN 130 PATIENTS WITH ANEURYSMAL SUBARACHNOID HEMORRHAGE

252

Angiographic findings in Buerger disease

253

Angiographic findings in monozygotic twins with coronary artery disease

254

Angiographic findings in patients undergoing catheterization for recurrent symptoms within 30 days of successful coronary intervention

255

Angiographic findings in tumoral calcinosis

256

Angiographic Findings of Patients with Blunt or Penetrating Extremity Injuries: Focus on Indications and Contraindications

257

Angiographic Findings, Time Course of Regional and Global Left Ventricular Function, and Clinical Outcome in Diabetic Patients With Acute Myocardial Infarction Treated With Primary Percutaneous Transluminal Coronary Angioplasty

258

Angiographic Follow-up of Internal Thoracic Artery for Free Bypass Grafting

259

Angiographic follow-up results of STent versus Atherectomy Randomized Trial (START)

260

Angiographic Lesion Severity and Subsequent Myocardial Infarction

261

Angiographic Localization of Potential Culprit Coronary Arteries in Patients With Interatrial Block Following a Positive Exercise Tolerance Test

262

Angiographic methods to assess human coronary angiogenesis

263

Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction

264

Angiographic Outcomes With Early Eptifibatide Therapy in Non–ST-Segment Elevation Acute Coronary Syndrome (from the EARLY ACS Trial)

265

Angiographic Patency of the Radial Artery Conduit in Coronary Artery Bypass Grafting

266

Angiographic Pattern of Restenosis Following Implantation of Overlapping Sirolimus-Eluting (Cypher) Stents

267

Angiographic Patterns of Drug-Eluting Stent Restenosis and One-Year Outcomes After Treatment With Repeated Percutaneous Coronary Intervention

268

Angiographic patterns of restenosis after paclitaxel-eluting stent implantation

269

Angiographic perfusion score: An angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction

270

Angiographic plaque complexity: the tip of the unstable plaque iceberg

271

Angiographic Predictors and Clinical Outcome of Acute Side Branch Occlusion after Coronary Artery Stent Implantation

272

Angiographic Predictors of 6-Month Patency of Bypass Grafts Implanted to the Right Coronary Artery: A Prospective Randomized Comparison of Gastroepiploic Artery and Saphenous Vein Grafts Original Research Article

273

Angiographic predictors of adverse outcomes in the modern interventional era

274

Angiographic predictors of graft patency and disease progression after coronary artery bypass grafting with arterial and venous grafts

275

Angiographic predictors of neointimal thickening after successful coronary wall healing following percutaneous revascularization

276

Angiographic predictors of new coronary occlusions

277

Angiographic Predictors of Recurrent Stent Thrombosis (from the Outcome of PCI for Stent-ThrombosIs MultIcentre STudy [OPTIMIST])

278

Angiographic predictors of reocclusion after thrombolysis: Results from the thrombolysis in myocardial infarction (TIMI) 4 trial

279

Angiographic presence of myocardial bridge after successful percutaneous transluminal coronary angioplasty

280

Angiographic presentation of coronary artery spasm in heart transplant recipients

281

Angiographic profile in patients with congenital anomalous origin of the coronary arteries

282

Angiographic restenosis rate in patients with chronic total occlusions and subtotal stenoses after initially successful intracoronary stent placement

283

Angiographic results after the use of a sutureless aortic connector for proximal vein graft anastomoses

284

Angiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial)

285

Angiographic Results of the First Human Experience With the Biolimus A9 Drug-Eluting Stent for De Novo Coronary Lesions

286

Angiographic right and left ventricular function in arrhythmogenic right ventricular dysplasia

287

Angiographic severity and extent of coronary artery disease in patients with type 1 diabetes mellitus

288

Angiographic severity and extent of coronary artery disease in type 1 diabetes

289

Angiographic severity of coronary artery disease in patients with metabolic syndrome

290

Angiographic severity of coronary narrowing is a surrogate marker for the extent of coronary atherosclerosis

291

Angiographic significance of a discordant ST-segment elevation of ≥5 millimeters in patients with ventricular-paced rhythm and acute myocardial infarction

292

Angiographic Stent Thrombosis After Routine Use of Drug-Eluting Stents in ST-Segment Elevation Myocardial Infarction: The Importance of Thrombus Burden Original Research Article

293

Angiographic study of aorta, coronary arteries, and left ventricular performance after neonatal arterial switch operation for simple transposition of the great arteries, ,

294

Angiographic study of Moyamoya disease and histological study in the external carotid artery system

295

Angiographic Surrogate End Points in Drug-Eluting Stent Trials: A Systematic Evaluation Based on Individual Patient Data From 11 Randomized, Controlled Trials Original Research Article

296

Angiographic variables predict increased riskfor adverse ischemic events after coronarystenting with glycoprotein IIb/IIIa inhibition: Results from the TARGET trial

297

Angiographic Versus Functional Severity of Coronary Artery Stenoses in the FAME Study: Fractional Flow Reserve Versus Angiography in Multivessel Evaluation

298

Angiographic, intravascular ultrasound and functional findings early after orthotopic heart transplantation

299

Angiographic, ultrasonic, and angioscopic assessment of the coronary artery wall and lumen area configuration after directional atherectomy: The mechanism revisited

300

Angiographical and computed tomographic findings in diffuse pulmonary arteriovenous fistulas

301

Angiographical study of ramus intermedius coronary artery in Basrah

302

Angiographically assessed coronary collateral circulation increases vulnerability to myocardial ischemia during vasodilator stress testing

303

Angiographically evident atherosclerotic stenosis associated with myocardial bridging and risk factors for the artery stenosis located proximally to myocardial bridging

304

Angiographically silent atherosclerosis detected by intravascular ultrasound in patients with familial hypercholesterolemi and familial combined hyperlipidemia: Correlation with high density lipoproteins

305

Angiographically silent left main disease detected by intravascular ultrasound: a marker for future adverse cardiac events

306

Angiography and arterial stimulation venous sampling in the localization of pancreatic neuroendocrine tumours

307

Angiography and interventional cardiology

308

Angiography and interventional cardiology Review Article

309

Angiography and revascularization in patients with heart failure following fibrinolytic therapy for ST-elevation acute myocardial infarction

310

Angiography of potential cardiac donors

311

Angiography versus intravascular ultrasound assessment of coronary stent placement: observations from the AVID study

312

Angiography; an Inducer of TGF-Β during Early Atherosclerosis

313

Angiography-proven liver metastases explain low efficacy of lymph node dissections in medullary thyroid cancer patients

314

Angiography-proven liver metastases explain low efficacy of lymph node dissections in medullary thyroid cancer patients

315

Angioid streaks and other ocular complications of Pagetʹs disease of bone

316

Angioimmunoblastic lymphadenopathy-like T-cell lymphoma A case report and immunologic study

317

Angiokeratoma corporis diffusum without systemic features in a young Kashmiri female: a rare occurrence

318

Angioleiomyoma in the tonsil: an uncommon tumour in a rare site

319

Angioleiomyoma of the diaphragm

320

Angioleiomyoma of the Hand: A Case Series and Review of the Literature

321

Angioleiomyoma: a benign tumor with karyotypic aberrations

322

Angiolipoma of the breast with microcalcification: Mammographic, sonographic, and histologic appearances

323

Angiolymphoid hyperplasia with eosinophilia

324

Angiolymphoid hyperplasia with eosinophilia

325

ANGIOLYMPHOID HYPERPLASIA WITH EOSINOPHILIA – A RARE ENTITY

326

Angioma serpiginosum successfully treated by a single session of intense pulsed light therapy

327

Angiomagnetic resonance imaging of iliofemorocaval venous thrombosis

328

Angiomatoid fibrous histiocytoma in mediastinum

329

Angiomatoid Fibrous Histiocytoma, A Great Mimicker – A Short Series of 3 Cases with EWSR1 Fusion

330

Angiomyofibroblastoma mimicking an inguinal hernia: a challenging diagnosis in a male patient

331

Angiomyofibroblastoma of the Vaginal Portion

332

Angiomyofibroblastoma of the Vulva

333

Angiomyogenesis using liposome based vascular endothelial growth factor-165 transfection with skeletal myoblast for cardiac repair

334

Angiomyolipoma and Malignant PEComa: Discussion of TwoRare Adrenal Tumors

335

Angiomyolipoma of the Adrenal Gland: A Case Report

336

Angiomyoma of the Hard Palate

337

Angiomyxolipoma; Report of a new case in subcutaneous tissue and review of the literature

338

Angiomyxoma Presenting as an Unusual Vaginal Mass

339

Angioneogenesis as a possible elusive triggering factor in rheumatoid arthritis

340

Angioneogenesis in rheumatoid arthritis

341

Angioneogenesis in rheumatoid arthritis

342

ANGIOPEPTIDES: NOVEL PEPTIDES THAT INDUCE ANGIOGENESIS

343

ANGIOPLASTY AND STENTING OF BASILAR ARTERY:SHORT-TERM OUTCOMES

344

ANGIOPLASTY AND STENTING OF BASILAR ARTERY:SHORT-TERM OUTCOMES

345

Angioplasty and stenting of the distal coronary anastomosis for graft failure immediately after coronary artery bypass grafting

346

Angioplasty for acute myocardial infarction in community hospital without surgical back-up: Response to Wharton and Angelini publications “should guidelines be changed?: Not whether but when”

347

Angioplasty for coarctation in different aged patients

348

Angioplasty for intermittent claudication

349

Angioplasty for lower-limb ischaemia: time for randomised controlled trials

350

Angioplasty for the late stent thrombosis, the new technical challenge: A single centre experience

351

Angioplasty Guidewire Velocity: A New Simple Method to Calculate Absolute Coronary Blood Velocity and Flow

352

Angioplasty in the stent era: results of a consecutive series of patients undergoing coronary angioplasty without surgical backup

353

Angioplasty increases coronary sinus F2-isoprostane formation: evidence for in vivo oxidative stress during PTCA

354

Angioplasty of a left anterior descending artery originating from the right sinus of Valsalva (discussion in decision making)

355

Angioplasty of atherosclerotic and fibromuscular renal artery stenosis: time course and predicting factors of the effects on renal function

356

Angioplasty of complex lesions in ischemic rest angina: Results of the Thrombolysis and Angioplasty in Unstable Angin (TAUSA) Trial

357

Angioplasty of the internal thoracic artery bypass-graft an alternative to reoperation

358

Angioplasty or Surgery for Multivessel Coronary Artery Disease: Comparison of Eligible Registry and Randomized Patients in the EAST Trial and Influence of Treatment Selection on Outcomes

359

Angioplasty through a stent side door

360

Angioplasty versus bypass surgery

361

Angioplasty versus bypass surgery

362

Angioplasty versus bypass surgery

363

Angioplasty versus intravenous thrombolysis for acute myocardial infarction

364

Angioplasty vs medical therapy in the treatment of unilateral atherosclerotic renal artery stenosis: A prospective randomized open blinded-endpoint trial

365

Angioplasty, inflammation, and antiplatelet agents

366

Angioplasty-induced superoxide anions and neointimal hyperplasia in the rabbit carotid artery: suppression by the isoflavone trans-tetrahydrodaidzein

367

Angiopoietin 2 Level in Type 2 Diabetic Patients with Cardiovascular Complications

368

Angiopoietin like protein 3 (Angptl3), fatty acid binding protein 4 (FABP4) and homeostasis model assessment of insulin resistance (HOMA-IR) among Indonesian obese non diabetic males

369

ANGIOPOIETIN-1 AND -2 MEDIATE PROINFLAMMATORY RESPONSES IN HUMAN ENDOTHELIAL CELLS

370

Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis

371

Angiopoietin-1 supports induction of hematopoietic activity in human CD34− bone marrow cells

372

Angiopoietin2 enhances doxorubin resistance in HepG2 cells by upregulating survivin and Ref-1 via MSK1 activation

373

ANGIOPOIETIN-2 IS AN AUTOCRINE REGULATOR OF ENDOTHELIAL CELL RESPONSIVENESS AND VASCULAR HOMEOSTASIS

374

Angiopoietin-like 4 Protein Elevates the Prosurvival Intracellular O2−:H2O2 Ratio and Confers Anoikis Resistance to Tumors

375

Angiopoietin-like protein 2 in psoriasis: a new linkage with metabolic syndrome

376

Angiopoietin-like protein 8 (betatrophin) may inhibit hepatocellular carcinoma through suppressing of the Wnt signaling pathway

377

Angiopoietin-like proteins: Another player in the metabolic field

378

Angiopoietin-like proteins: potential new targets for metabolic syndrome therapy

379

Angiopoietin-like-4 is a potential angiogenic mediator in arthritis

380

Angiopoietins in angiogenesis

381

Angiopoietins in malignancy

382

Angiopoietins: a link between angiogenesis and inflammation

383

Angiosarcoma after conservative treatment and radiation therapy for adenocarcinoma of the breast

384

Angiosarcoma as a sequela of breast cancer treatment with lumpectomy and radiotherapy

385

Angiosarcoma at Dialysis Fistula Site in a Patient on Continuous Ambulatory Peritoneal Dialysis

386

Angiosarcoma in the right atria demonstrated by fusion images of multislice computed tomography and positron emission tomography using F-18 Fluoro-Deoxyglucose

387

Angiosarcoma of Kidney A Case Report and Review of Literature

388

Angiosarcoma of the breast after quadrantectomy and postoperative radiotherapy for carcinoma

389

Angiosarcoma of the breast: a 30 year perspective with an optimistic outlook

390

Angiosarcoma of the chest wall

391

Angiosarcoma of the Liver Presenting with Esophageal Bleeding and Arterio-portal Shunts

392

Angiosarcoma of the liver: MR imaging pre- and post-chemotherapy

393

Angiosarcoma of the pericardium presenting as hemorrhagic pleuropericarditis, cardiac tamponade, and thromboembolic phenomena

394

Angiosarcoma of the Right Atrium with Extension to SVC and IVC Presenting with Complete Heart Block and Significant Pericardial Effusion

395

Angiosarcoma of the right atrium: A diagnostic dilemma

396

Angiosarcoma of the small intestine

397

Angiosarcoma: complication of breast conservation treatment

398

Angiosarcome mammaire primitif : à propos de deux cas

399

Angioscopic and Virtual Histology Intravascular Ultrasound Characteristics of Culprit Lesion Morphology Underlying Coronary Artery Thrombosis

400

Angioscopic Assessment of Coronary Lesions Underlying Thrombus

401

Angioscopic characteristics of coronary narrowing in patients with recurrent myocardial ischemia after myocardial infarction

402

Angioscopic Comparison of Neointimal Coverage Between Zotarolimus- and Sirolimus-Eluting Stents

403

Angioscopic Coronary Macromorphology After Thrombolysis in Acute Myocardial Infarction

404

Angioscopic detection of residual pulmonary thrombi in the differential diagnosis of pulmonary embolism

405

Angioscopic evaluation of angiographically complex coronary lesions,

406

Angioscopic evaluation of atherosclerotic plaques: Validation by histomorphologic analysis and association with stable and unstable coronary syndromes

407

Angioscopic evaluation of neointima coverage: Sirolimus drug-eluting stent versus bare metal stent

408

Angioscopic Evaluation of Rotational Atherectomy Followed by Additional Balloon Angioplasty Versus Balloon Angioplasty Alone in Coronary Artery Disease: Prospective, Randomized Study

409

Angioscopic findings during coronary angioplasty of coronary occlusions

410

Angioscopic findings of delayed healing at sites of sirolimus-eluting stent overlap after 21-month implantation

411

Angioscopic follow-up study of coronary ruptured plaques in nonculprit lesions Original Research Article

412

Angioscopic identification of coronary thrombus in patients with postinfarction angina

413

Angioscopic versus angiographic detection of thrombus during coronary interventional procedures

414

Angioscopy of Culprit Coronary Lesions in Unstable Angina Pectoris and Correlation of Clinical Presentation With Plaque Morphology

415

Angioscopy variables predictive of early angiographic outcome after excimer laser-assisted coronary angioplasty

416

Angioseal use after antegrade femoral arteriotomy in patients undergoing percutaneous revascularization for critical limb ischemia: A case series

417

Angiosome-targeted isolated tibial angioplasty for healing of ischemic foot ulcer: a retrospective study

418

Angiosperm DNA contamination by endophytic fungi: Detection and methods of avoidance

419

Angiosperms (seagrass) within the EU water framework directive: A UK perspective

420

Angiostrongylus eosinophilic meningitis in Egypt

421

Angiostrongylus vasorum from South America and Europe represent distinct lineages

422

Angiotenin II and vacular endothelial growth factor in the vitreou fluid of patient with diabetic macular edema and other retinal diorder

423

Angiotensin (1–7) and Apelin co-therapy: New strategy for heart failure treatment of rats

424

Angiotensin (1-7) Inhibits Ang II-mediated ERK1/2 Activation by Stimulating MKP-1 Activation in Vascular Smooth Muscle Cells

425

Angiotensin 1-7 Administration Increases Renal Blood Flow in the Absence of Bradykinin B2 Receptor in Ovariectomized Estradiol Treated Rats: The Role of Mas Receptor

426

Angiotensin 1-7 Receptor and Angiotensin II Receptor 2 Blockades Prevent the Increased Serum and Kidney Nitric Oxide Levels in Response to Angiotensin II Administration: Gender-Related Difference

427

Angiotensin 2 type 1 receptor blocker attenuates atrial structural remodeling in spontaneously hypertensive rats: Role of the suppression of atrial oxidative stress

428

Angiotensin and asymmetric fetal growth

429

Angiotensin and vascular fibrinolytic balance

430

Angiotensin antagonists and renal ischemia/reperfusion: Possible modulation by L-carnitine

431

Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade

432

Angiotensin blockade for hypertension: a promise fulfilled

433

Angiotensin Blockade Inhibits Increased JNKs, AP-1 and NF- κ B DNA-binding Activities in Myocardial Infarcted Rats

434

Angiotensin Blockade Inhibits SIF DNA Binding Activities via STAT3 after Myocardial Infarction

435

Angiotensin converting enzyme (ACE D/I) polymorphism and its relation to liver fibrosis progression in Egyptian patients with chronic hepatitis C virus infection

436

Angiotensin Converting Enzyme (ACE) Activity Levels in Insulin-independent Diabetes Mellitus and Effect of ACE levels on Diabetic Patients with Nephropathy

437

Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease

438

Angiotensin converting enzyme (ACE) gene expression in experimentally induced liver cirrhosis in rats

439

Angiotensin converting enzyme (ACE) inhibitory, antihypertensive and antihyperlipidaemic activities of protein hydrolysates from Rhopilema esculentum

440

Angiotensin Converting Enzyme and Myofibroblasts during Tissue Repair in the Rat Heart

441

Angiotensin converting enzyme gene — a candidate gene for addiction to smoking?

442

Angiotensin Converting Enzyme Gene I/D Polymorphism in Pakistani Rheumatic Heart Disease Patients and Healthy Controls

443

Angiotensin converting enzyme gene insertion/deletion polymorphism, angiotensinogen gene polymorphisms, family history of hypertension, and childhood blood pressure

444

Angiotensin Converting Enzyme Gene Insertion/Deletion Variant and Familial Mediterranean Fever-related Amyloidosis

445

Angiotensin converting enzyme gene polymorphism and activity in Turkish patients with essential hypertension

446

Angiotensin converting enzyme gene polymorphism and the course of angiographically defined coronary artery disease

447

Angiotensin Converting Enzyme Gene Polymorphism in Aizheimers Disease

448

Angiotensin Converting Enzyme Gene Polymorphism in Essential Hypertension Based on Ambulatory Blood Pressure Monitoring

449

Angiotensin Converting Enzyme Gene Polymorphism in Iranian Patients with Type 2 Diabetes

450

Angiotensin Converting Enzyme Gene Polymorphism Is Not Related to Essential Hypertension in a Greek Population

451

Angiotensin Converting Enzyme I/D Polymorphism and Chronic Hepatitis C Virus Infection

452

Angiotensin Converting Enzyme I/D Polymorphism in Egyptian Patients with Type 2 Diabetes Mellitus

453

Angiotensin converting enzyme inhibition and angiotensin II AT1-receptor blockade reduce the levels of asymmetrical NG, NG-dimethylarginine in human essential hypertension

454

Angiotensin converting enzyme inhibition by captopril influences cardiac work in healthy hearts

455

Angiotensin Converting Enzyme Inhibition Corrects Na+/H+ Exchanger Overactivity in Essential Hypertension

456

Angiotensin converting enzyme inhibition, with quinapril, improves endothelial vasomotor dysfunction in patients with coronary artery disease: The TREND study (trial on reversing endothelial dysfunction)

457

Angiotensin converting enzyme inhibitor as an additive treatment after successful balloon dilation of a critical pulmonary valve stenosis

458

Angiotensin converting enzyme inhibitor captopril does not improve exercise tolerance or reduce exercise induced myocardial ischemi in patients with angin pectoris

459

Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese

460

Angiotensin Converting Enzyme Inhibitor-related Angioedema: A Case of an Unexpected Death

461

ANGIOTENSIN CONVERTING ENZYME- INHIBITORS ASSOCIATED COUGH: A PROSPECTIVE EVALUATION IN HYPERTENSIVES

462

Angiotensin Converting Enzyme Inhibitors, A Risk Factor of Poor Outcome in Diabetic Patients with COVID-19 Infection

463

Angiotensin Converting Enzyme Insertion/Deletion Gene Polymorphism: An Observational Study among Diabetic Hypertensive Subjects in Malaysia

464

Angiotensin- Converting Enzyme Insertion/Deletion Polymorphism and Its Association with Coronary Artery Disease in an Iranian Population

465

Angiotensin converting enzyme insertion/deletion polymorphism in sporadic and familial Alzheimerʹs disease and longevity

466

Angiotensin I converting enzyme (ACE) gene polymorphism and essential hypertension in Japan: Ethnic difference of ACE genotype

467

Angiotensin I converting enzyme (ACE) inhibitory peptide derived from the sauce of fermented blue mussel, Mytilus edulis

468

Angiotensin I converting enzyme gene polymorphism and insulin resistance in patients with angina pectoris

469

Angiotensin I Converting Enzyme Gene Polymorphism in Chinese Patients With Hypertension

470

Angiotensin I Converting Enzyme Inhibitory Activities of Hydroalcoholic Extracts of Nardostachys jatamansi, Prangos ferulacea and Marrubium vulgare

471

Angiotensin I Modulates Ca-transport Systems in the Rat Heart Through Angiotensin II

472

Angiotensin I retention behavior on Butyl-Sepharose under linear loading chromatographic conditions

473

Angiotensin I-Converting Enzyme (ACE) Gene Polymorphism in Relation to Physical Performance, Cognition and Survival—A Follow-up Study of Elderly Danish Twins

474

Angiotensin I–converting enzyme (ACE) inhibitors and restenosis after coronary artery stenting in patients with the DD genotype of the ACE gene

475

Angiotensin I-converting enzyme (ACE) inhibitory activities of sardinelle (Sardinella aurita) by-products protein hydrolysates obtained by treatment with microbial and visceral fish serine proteases

476

Angiotensin I-converting enzyme (ACE) inhibitory peptides derived from arachin by simulated gastric digestion

477

Angiotensin I–converting enzyme and plasminogen activator inhibitor-1 gene variants: risk of mortality and fatal cardiovascular disease in an elderly population-based cohort

478

Angiotensin I–converting enzyme gene insertion/deletion polymorphism and endometrial human cancer in normotensive and hypertensive women

479

Angiotensin I-Converting Enzyme Gene Polymorphism and Acute Response to Captopril in Essential Hypertension

480

Angiotensin I-converting enzyme gene polymorphism in a low-risk European population for coronary artery disease Original Research Article

481

Angiotensin I-converting enzyme inhibitor derived from soy protein hydrolysate and produced by using membrane reactor

482

Angiotensin I-converting enzyme inhibitory compounds in white and red wines

483

Angiotensin I-converting enzyme inhibitory oligo-tyrosine peptides synthesized by α-chymotrypsin

484

Angiotensin I-converting enzyme inhibitory peptide from yellowfin sole (Limanda aspera) frame protein and its antihypertensive effect in spontaneously hypertensive rats

485

Angiotensin I-converting enzyme inhibitory peptides in douchi, a Chinese traditional fermented soybean product

486

Angiotensin I-converting enzyme inhibitory properties of lentil protein hydrolysates: Determination of the kinetics of inhibition

487

Angiotensin I–converting enzyme insertion/insertion genotype as a genetic risk factor for cardiovascular disease

488

Angiotensin I-converting enzyme-inhibitory peptide fractions from albumin 1 and globulin as obtained of amaranth grain

489

Angiotensin II (Ang II) stimulates sympathetic nerve (SNS) activity through activation of oxidative stress

490

Angiotensin II (AngII) activates nuclear factor-κB via AT1 and AT2 receptors in the kidney

491

Angiotensin II activates intermediate-conductance Ca2+-activated K+ channels in arterial smooth muscle cells

492

Angiotensin II Activates Stat5 Through Jak2 Kinase in Cardiac Myocytes

493

Angiotensin II activation of Src mediates ERK stimulation in human vascular smooth muscle cells

494

Angiotensin II and atherosclerosis

495

Angiotensin II and cardiomyocyte apoptosis in the SHR

496

Angiotensin II and Intracellular Calcium of Adult Cardiac Fibroblasts

497

Angiotensin II and the pathophysiology of cardiovascular remodeling

498

Angiotensin II and trials of cardiovascular outcomes

499

Angiotensin II antagonists block ethanol effects on the aerial righting reflex

500

Angiotensin II antagonists demonstrate greater long-term persistence versus other antihypertensive medications

501

Angiotensin II antagonists for hypertension: are there differences in efficacy?

502

Angiotensin II antagonists for hypertension: there are differences in efficacy

503

Angiotensin II antagonists for hypertension: there are differences in efficacy: The reply

504

Angiotensin II AT1 Receptor Blockade Improves Renal Perfusion in Hypercholesterolemia

505

Angiotensin II AT1 receptor blockade normalizes CD11b+ monocyte production in bone marrow of hypercholesterolemic monkeys

506

Angiotensin II AT1 receptor gene polymorphism and microalbuminuria in essential hypertension

507

Angiotensin II atherogenicity in apolipoprotein E deficient mice is associated with increased cellular cholesterol biosynthesis

508

Angiotensin II Differentially Induces Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 Production and Disturbs MMP/TIMP Balance

509

Angiotensin II directly inhibits protein synthesis in murine myotubes

510

Angiotensin II Elevates Nitric Oxide Synthase 3 Expression and Nitric Oxide Production Via a Mitogen-Activated Protein Kinase Cascade in Ovine Fetoplacental Artery Endothelial Cells

511

Angiotensin II enhances cardiac Na+/Ca2+ exchanger current via an autocrine release of endothelin

512

Angiotensin II Enhances the Expression of Giα in A10 Cells (Smooth Muscle): Relationship with Adenylyl Cyclase Activity

513

Angiotensin II increases expression and secretion of cathepsin F in cultured human monocyte-derived macrophages: An angiotensin II type 2 receptor-mediated effect

514

Angiotensin II increases phosphodiesterase 5A expression in vascular smooth muscle cells: A mechanism by which angiotensin II antagonizes cGMP signaling

515

Angiotensin II increases the expression of lectin-like oxidized low-density lipoprotein receptor-1 in human vascular smooth muscle cells via a lipoxygenase-dependent pathway

516

Angiotensin II increases the release of endothelin-I from human cultured endothelial cells but does not regulate its circulating levels

517

Angiotensin II induced hyperplasia and hypertrophy in human vascular smooth muscle cells are mediated via AT1 receptors

518

Angiotensin II Induces Apoptosis of Adult Ventricular MyocytesIn Vitro

519

Angiotensin II induces DNA injury in human umbilical artery smooth muscle cells via a mechanism which involves hydrogen peroxide

520

Angiotensin II induces IL-6 expression and the Jak-STAT3 pathway in aortic adventitia of LDL receptor-deficient mice

521

Angiotensin II induces interleukin-6 synthesis in osteoblasts through ERK1/2 pathway via AT1 receptor

522

Angiotensin II induces mitochondrial dysfunction and promotes apoptosis via JNK signalling pathway in primary mouse calvaria osteoblast

523

Angiotensin II Induces Nuclear Factor- κ B Activation in Cultured Neonatal Rat Cardiomyocytes Through Protein Kinase C Signaling Pathway

524

Angiotensin II induces phosphorylation of glucose-regulated protein-75 in WB rat liver cells

525

Angiotensin II infusion induces site-specific intra-laminar hemorrhage in macrophage colony-stimulating factor-deficient mice

526

Angiotensin II inhibition and prevention of atrial fibrillation and stroke

527

Angiotensin II inhibition during myocardial ischemia–reperfusion in dogs: effects on leukocyte infiltration, nitric oxide synthase isoenzymes activity and left ventricular ejection fraction

528

Angiotensin II inhibition of Ca2+ currents is independent of ATR1 angiotensin II receptor activation in rat adult vagal afferent neurons

529

Angiotensin II Inhibits Insulin-Induced egr-1 Expression in Mesangial Cells

530

Angiotensin II inhibits the forearm vascular response to increased arterial pressure in humans

531

Angiotensin II Mechanisms in Ischemic Heart Disease: Pathophysiology and Survival

532

Angiotensin II mechanisms in the renal responses to hypertension and diabetes mellitus.

533

Angiotensin II Modulates ANP-R2/ANP-C Receptor-mediated Inhibition of Adenylyl Cyclase in Vascular Smooth Muscle Cells: Role of Protein Kinase C

534

Angiotensin II Plays a Critical Role in Alcohol-Induced Cardiac Nitrative Damage, Cell Death, Remodeling, and Cardiomyopathy in a Protein Kinase C/Nicotinamide Adenine Dinucleotide Phosphate Oxidase–Dependent Manner

535

Angiotensin II Plays an Important Role in Maintaining Blood Pressure in Postmenopausal Women Receiving Hormone Replacement Therapy

536

Angiotensin II Potentiates DNA Synthesis in AT-1 Transformed Cardiomyocytes

537

Angiotensin II promotes ICAM-1 expression in vitro and soluble ICAM-1 secretion in vivo

538

Angiotensin II receptor antagonism does not prevent tolerance to continuous transdermal nitroglycerin

539

Angiotensin II Receptor Antagonist Blocks the Expression of Connexin43 Induced by Cyclical Mechanical Stretch in Cultured Neonatal Rat Cardiac Myocytes

540

Angiotensin II receptor antagonists Review Article

541

Angiotensin II receptor blockade and end-organ protection

542

Angiotensin II receptor blockade by losartan reduces the incidence of heart failure after an MI in rat

543

Angiotensin II receptor blockade does not improve left ventricular function andremodeling in subacute mitral regurgitation in the dog

544

Angiotensin II receptor blockade in diabetic nephropathy

545

Angiotensin II receptor blockade in diabetic nephropathy

546

Angiotensin II receptor blockade reduces expression of basic fibroblast growth factor mRNA in the balloon injured rat carotid artery. Quantification by competitive polymerase chain reaction

547

Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: The Losartan Intervention For End point reduction in hypertension (LIFE) study Original Research Article

548

ANGIOTENSIN II RECEPTOR BLOCKER VALSARTAN ENHANCES GLUCOSE-INDUCED INSULIN SECRETION

549

Angiotensin II receptor blockers and angiotensin converting enzyme inhibitors: implication of radical scavenging and transition metal chelation in inhibition of advanced glycation end product formation

550

Angiotensin II Receptor Blockers and Risk of Cancer in Patients With Systemic Hypertension

551

Angiotensin II Receptor Blockers Downsize Adipocytes in Spontaneously Type 2 Diabetic Rats With Visceral Fat Obesity

552

Angiotensin II receptor blockers: review of the binding characteristics

553

Angiotensin II Receptor Subtypes and Biological Responses in the Rat Heart

554

Angiotensin II Receptor Type 1 mRNA is Upregulated in Atria of Patients with End-stage Heart Failure

555

Angiotensin II receptors from peritransplantation through first-year post-transplantation and the risk of transplant coronary artery disease Original Research Article

556

Angiotensin II reduces alcohol intake and choice in water- or food-restricted rats

557

Angiotensin II regulates AT2 subtype receptor promoter activity and expression in rat primary endothelial cell

558

Angiotensin II regulates the cell cycle of vascular smooth muscle cells from SHR

559

Angiotensin II Release From Rabbit Intrarenal Arteries: A Critical Assessment

560

Angiotensin II signals mechanical stretch-induced cardiac matrix metalloproteinase expression via JAK-STAT pathway

561

Angiotensin II Stimulated Expression of Transforming Growth Factor-β1in Cardiac Fibroblasts and Myofibroblasts

562

Angiotensin II stimulates cardiac chloride/bicarbonate exchange activity by phosphorylation of serine 67 of AE3

563

Angiotensin II stimulates left ventricular hypertrophy in hypertensive patients independently of blood pressure

564

Angiotensin II stimulates left ventricular hypertrophy in hypertensive patients independently of blood pressure

565

Angiotensin II stimulates macrophage-mediated oxidation of low density lipoproteins Original Research Article

566

Angiotensin II stimulates phosphorylation and nuclear accumulation of R-Smad 2 in cultured cardiac fibroblasts: T-type Ca channel blockade in vascular smooth muscle cells causes G1S cell cycle arrest

567

Angiotensin II stimulates synthesis of vascular smooth muscle cell proteoglycans with enhanced low density lipoprotein binding properties

568

Angiotensin II subtype-1 receptor antagonists improve hemodynamic and renal changes without affecting glucose metabolisms in genetic rat model of non–insulin-dependent diabetes mellitus

569

Angiotensin II type 1 (AT1) receptor blockade in hypertensive women: benefits of candesartan cilexetil versus enalapril or hydrochlorothiazide

570

Angiotensin II type 1 receptor (A1166C) gene polymorphism in Egyptian adult hemodialysis patients

571

Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure

572

Angiotensin II type 1 receptor antagonists inhibit cell proliferation and angiogenesis in breast cancer

573

Angiotensin II Type 1 Receptor Blockade Abolishes Specific KATPChannel Gene Expression in Rats with Myocardial Ischemia

574

Angiotensin II type 1 receptor blockade improves cardiac expression of hsp72 and tolerance against ischemia/reperfusion injury in insulin resistance rat

575

Angiotensin II type 1 receptor blocker losartan attenuates locomotor, anxiety-like behavior, and passive avoidance learning deficits in a sub-chronic stress model

576

Angiotensin II type 1 receptor blocker telmisartan suppresses superoxide production and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice

577

Angiotensin II type 1 receptor blockers reduce tissue factor activity and plasminogen activator inhibitor type-1 antigen in hypertensive patients: a randomized, double-blind, placebo-controlled study

578

Angiotensin II Type 1 Receptor Gene A1166C Polymorphism Was Not Associated With Acute Coronary Syndrome in an Iranian Population

579

Angiotensin II type 1 receptor gene polymorphism and mitral valve prolapse syndrome

580

Angiotensin II Type 1 Receptor Gene Polymorphism Is Associated With Increase of Left Ventricular Mass But Not With Hypertension

581

Angiotensin II type 1 receptor polymorphisms in the cardiovascular health study: relation to blood pressure, ethnicity, and cardiovascular events

582

Angiotensin II type 1-receptor antagonism prevents type IIA secretory phospholipase A2-dependent lipid peroxidation

583

Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists

584

Angiotensin II type-I receptor antagonists in the treatment of heart failure

585

Angiotensin II upregulates transforming growth factor-β type I receptor on rat vascular smooth muscle cells

586

Angiotensin II, oxidative stress, and extracellular matrix degradation during transition to LV failure in rats with hypertension

587

Angiotensin II, Transforming Growth Factor-β1and Repair in the Infarcted Heart

588

Angiotensin II, VEGF, and diabetic retinopathy

589

Angiotensin II, VEGF, and diabetic retinopathy

590

Angiotensin II, VEGF, and diabetic retinopathy

591

Angiotensin II-dependent growth of vascular smooth muscle cells requires transactivation of the epidermal growth factor receptor via a cytosolic phospholipase A2-mediated release of arachidonic acid

592

Angiotensin II-induced C-reactive protein generation: Inflammatory role of vascular smooth muscle cells in atherosclerosis

593

Angiotensin II-induced ionic currents and signalling pathways in submandibular ganglion neurons

594

Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats

595

Angiotensin II-Mediated apoptosis and P53 expression in human cardiomyocytes

596

Angiotensin II-mediated Growth and Antigrowth Effects in Cultured Neonatal Rat Cardiac Myocytes and Fibroblasts

597

Angiotensin IV-evoked vasoprotection is conserved in advanced atheroma

598

Angiotensin receptor antagonists

599

Angiotensin receptor antagonists: focus on losartan

600

Angiotensin receptor blockade improves arterial distensibility and reduces exercise-induced pressor responses in obese hypertensive patients with the metabolic syndrome

601

Angiotensin receptor blockade improves myocardial beta-adrenergic receptor signaling in postinfarction left ventricular remodeling: A possible link between beta-adrenergic receptor kinase-1 and protein kinase C epsilon isoform Original Research Article

602

Angiotensin Receptor Blocker and N-Acetyl Cysteine for Reduction of Proteinuria in Patients With Type 2 Diabetes Mellitus

603

Angiotensin Receptor Blockers – finally the evidence is coming in: IDNT and RENAAL

604

Angiotensin Receptor Blockers and Cardiovascular Protection: Are We ONTARGET?

605

Angiotensin receptor blockers and diuretics as combination therapy: clinical implications

606

Angiotensin Receptor Blockers and Magnesium Status in Essential Hypertension

607

Angiotensin receptor blockers in heart failure: A work in progress

608

Angiotensin receptor blockers in heart failure: meta-analysis of randomized controlled trials

609

Angiotensin receptor blockers in the prevention of atrial fibrillation recurrence: Need for a definitive trial

610

Angiotensin receptor blockers in the prevention of atrial fibrillation recurrence: Need for a definitive trial

611

Angiotensin Receptor Blockers: Current Status and Future Prospects

612

Angiotensin receptor blockers: how important is selectivity?

613

Angiotensin receptor blockers—finally the evidence is coming in: IDNT and RENAAL

614

Angiotensin receptor neprilysin inhibitor in inotrope dependent heart failure patients: A case series

615

Angiotensin Receptor-1 Blocker Inhibits Atherosclerotic Changes and Endothelial Disruption of the Aortic Valve in Hypercholesterolemic Rabbits Original Research Article

616

Angiotensin Receptors in Cardiac and Renal Hypertrophy in Rats

617

Angiotensin receptors: history and mysteries

618

Angiotensin type 1 receptor antagonism reverses abnormal coronary vasomotion in atherosclerosis

619

Angiotensin Type 2 Receptor Gene Polymorphisms and Susceptibility to Preeclampsia

620

Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons

621

Angiotensin-(1–7) and vasopeptidase inhibition

622

Angiotensin-(1–7) central administration induces anxiolytic-like effects in elevated plus maze and decreased oxidative stress in the amygdala

623

ANGIOTENSIN, BRADYKININ AND CONVERTING ENZYME IN IMPOSED AND PHYSIOLOGICAL FLOW-RELATED ARTERIAL REMODELING.

624

Angiotensin, fibrinolysis, and vascular homeostasis

625

Angiotensin-Converting Enzyme (ACE) Inhibitor Angioedema: The Silent Epidemic

626

Angiotensin-converting enzyme (ACE) inhibitors revert abnormal right ventricular filling in patients with restrictive left ventricular disease

627

Angiotensin-converting enzyme (ACE), angiotensinogen (AGT), and angiotensin II type 1 receptor (AT1R) gene polymorphisms in generalized aggressive periodontitis

628

Angiotensin-converting enzyme (CD143) is abundantly expressed by dendritic cells and discriminates human monocyte-derived dendritic cells from acute myeloid leukemia-derived dendritic cells

629

angiotensin-converting enzyme 2 (ace2) gene polymorphism in patients with type 2 diabetes (t2dm) in thi-qar, iraq

630

Angiotensin-converting enzyme 2 acts as a potential molecular target for pancreatic cancer therapy

631

Angiotensin-converting enzyme activity and contractile effects of angiotensin I and II in human uteroplacental arteries

632

Angiotensin-converting enzyme and apolipoprotein B polymorphisms in coronary artery disease

633

Angiotensin-Converting Enzyme and Heart Chymase gene Polymorphisms in Hypertrophic Cardiomyopathy

634

Angiotensin-converting enzyme and p22phox polymorphisms and the risk of coronary heart disease in a low-risk Spanish population

635

Angiotensin-converting Enzyme and Renin Inhibition Activities, Antioxidant Properties, Phenolic and Flavonoid Contents of Cuphea ignea A. DC.

636

Angiotensin-Converting Enzyme Assay Optimization:Influence of Various Buffers and Their Concentrations

637

Angiotensin-converting enzyme gene deletion polymorphism modulation of onset of symptoms and survival rate of patients with heart failure

638

Angiotensin-converting enzyme gene I/D polymorphism and carotid artery disease in renovascular hypertension

639

Angiotensin-converting enzyme gene insertion/deletion polymorphism and cardiovascular disease: Identifying the guideposts for navigating the genetics landscape

640

Angiotensin-converting enzyme gene polymorphism and common carotid stiffness: The Rotterdam study

641

Angiotensin-converting enzyme gene polymorphism in a cohort of coronary angiography patients

642

Angiotensin-converting enzyme gene polymorphism in Japanese patients with hypertrophic cardiomyopathy

643

Angiotensin-converting enzyme gene polymorphism in preeclampsia and normal pregnancy

644

Angiotensin-Converting Enzyme Gene Polymorphism in Systemic Hypertension

645

Angiotensin-converting enzyme gene polymorphism influences degree of left ventricular hypertrophy and its regression in patients undergoing operation for aortic stenosis

646

Angiotensin-converting enzyme gene polymorphism interacts with left ventricular ejection fraction and brain natriuretic peptide levels to predict mortality after myocardial infarction

647

Angiotensin-converting enzyme genetic variants do not influence response to risperidone in autistic children

648

Angiotensin-converting enzyme genotype affects skeletal muscle strength in elite athletes

649

Angiotensin-Converting Enzyme Genotype Predicts Cardiac and Autonomic Responses to Prolonged Exercise Original Research Article

650

Angiotensin-Converting Enzyme Genotypes and Risk for Myocardial Infarction in Women

651

Angiotensin-Converting Enzyme I/D Polymorphism in Behçet’s Disease

652

Angiotensin-converting enzyme inhibition after myocardial infarction: the trandolapril cardiac evaluation study

653

Angiotensin-Converting enzyme inhibition and angiogenesis in myocardium of obese Zucker rats

654

Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet

655

Angiotensin-converting enzyme inhibition but not angiotensin II type 1 receptor antagonism augments coronary release of tissue plasminogen activator in hypertensive patients

656

Angiotensin-converting enzyme inhibition enhances a subthreshold stimulus to elicit delayed preconditioning in pig myocardium

657

Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation Original Research Article

658

Angiotensin-converting enzyme inhibition in patients with coronary artery disease and preserved left ventricular function: Ischemia Management with Accupril post–bypass graft via inhibition of angiotensin-converting enzyme (IMAGINE) compared with the othe

659

Angiotensin-converting enzyme inhibition is associated with reduced troponin release in non–ST-elevation acute coronary syndromes

660

Angiotensin-converting enzyme inhibition limits dysfunction in adjacent noninfarcted regions during left ventricular remodeling

661

Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction

662

Angiotensin-converting enzyme inhibition restores the diffusing capacity for carbon monoxide in patients with chronic heart failure by improving the molecular diffusion across the alveolar capillary membrane

663

Angiotensin-converting enzyme inhibition to enhance vascular health—clinical and research models

664

Angiotensin-converting enzyme inhibition, autonomic activity, and hemodynamics in patients with heart failure who perform isometric exercise

665

Angiotensin-Converting Enzyme Inhibitor as a Marker, Not a Risk Factor, for Poor Prognosis

666

Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction Original Research Article

667

Angiotensin-converting enzyme inhibitor compliance and dosing among patients with heart failure,

668

Angiotensin-converting enzyme inhibitor dosages in elderly patients with heart failure

669

Angiotensin-converting enzyme inhibitor dosing in heart failure: What is optimal?

670

Angiotensin-converting enzyme inhibitor for epirubicin-induced dilated cardiomyopathy

671

Angiotensin-converting enzyme inhibitor meta-analysis provides misleading conclusion

672

Angiotensin-Converting Enzyme Inhibitor Prevents Plasminogen Activator Inhibitor-1 Expression in a Rat Model with Cardiovascular Remodeling Induced by Chronic Inhibition of Nitric Oxide Synthesis

673

Angiotensin-Converting Enzyme Inhibitor Therapy Affects Left Ventricular Mass in Patients With Ejection Fraction >40% After Acute Myocardial Infarction

674

Angiotensin-Converting Enzyme Inhibitor Therapy at the Time of Coronary Artery Bypass Surgery: When a Friend Turns Mean-Spirited

675

Angiotensin-converting enzyme inhibitor treatment after myocardial infarction: A selective approach for maximum benefit

676

Angiotensin-converting enzyme inhibitor use in survivors of acute myocardial infarction

677

Angiotensin-Converting Enzyme Inhibitor, Angiotensin Receptor Blocker Use, and Mortality in Patients With Chronic Kidney Disease

678

Angiotensin-converting enzyme inhibitors after myocardial infarction: Indications and timing

679

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease

680

Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study

681

Angiotensin-converting enzyme inhibitors and myocardial infarction: A class effect?

682

Angiotensin-Converting Enzyme Inhibitors and Outcome Among Patients With Heart Failure and Renal Insufficiency: Need for a Prospective Study

683

Angiotensin-converting enzyme inhibitors and β-blockers in long-term treatment of dilated cardiomyopathy

684

Angiotensin-converting enzyme inhibitors as a cause of unilateral tongue angioedema in a 68-year-old woman

685

Angiotensin-converting enzyme inhibitors as a new therapy for atrial fibrillation? Controversy

686

Angiotensin-converting enzyme inhibitors as adjunctive therapy in patients with persistent atrial fibrillation

687

Angiotensin-Converting Enzyme Inhibitors Can Increase the Transvalvular Gradient Among Patients With Aortic Stenosis

688

Angiotensin-converting enzyme inhibitors in adults after the mustard procedure

689

Angiotensin-converting enzyme inhibitors in adults with cyanotic congenital heart disease

690

Angiotensin-Converting Enzyme Inhibitors in Coronary Artery Disease and Preserved Left Ventricular Systolic Function: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Original Research Article

691

Angiotensin-converting enzyme inhibitors in the management of congestive heart failure: A pharmaceutical industry perspective, ,

692

Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers for Prevention of Type 2 Diabetes: A Meta-Analysis of Randomized Clinical Trials Original Research Article

693

Angiotensin-Converting Enzyme Inhibitors Potentiate Preconditioning Through Bradykinin B2 Receptor Activation in Human Heart

694

Angiotensin-converting enzyme inhibitors prevent LDL-induced endothelial dysfunction by reduction of asymmetric dimethylarginine level

695

Angiotensin-converting enzyme inhibitors reveal non-NO-, non-prostacycline-mediated endothelium-dependent relaxation in internal thoracic artery of hypertensive patients

696

Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Antagonists and Calcium Channel Blocking Agents: Review of Potential Benefits and Possible Adverse Reactions

697

Angiotensin-converting enzyme inhibitors, beta-blockers, and mortality in systolic heart failure

698

Angiotensin-converting enzyme inhibitors: a new therapy for atrial fibrillation?

699

Angiotensin-converting enzyme inhibitors: ischemia is not the correct measure of benefit

700

Angiotensin-converting enzyme inhibitors: optimal management of cardiovascular risk

701

Angiotensin-Converting Enzyme Insertion/Deletion Gene Polymorphism in General Population of West Azarbaijan, Iran

702

Angiotensin-converting enzyme insertion/deletion polymorphism and restenosis after coronary angioplasty in unstable angina pectoris

703

Angiotensin-converting enzyme insertion/deletion polymorphism in angina pectoris with normal coronary arteriograms

704

Angiotensin-converting enzyme polymorphism (I/D) and coronary heart disease in young adults

705

Angiotensin-converting enzyme polymorphism (I/D) and coronary heart disease in young adults: Reply

706

Angiotensin-Converting Enzyme-2 Overexpression Improves Left Ventricular Remodeling and Function in a Rat Model of Diabetic Cardiomyopathy

707

Angiotensin-converting enzymeinhibitors and angiotensin iireceptor blockers synergistically increasecoronary blood flow in canine ischemic myocardium: Role of bradykinin

708

Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training

709

Angiotensin-converting-enzyme inhibition therapy in altitude polycythaemia: a prospective randomised trial

710

Angiotensin-converting-enzyme inhibitors in early pregnancy

711

Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials

712

Angiotensin-I converting enzyme inhibitory peptides from antihypertensive skate (Okamejei kenojei) skin gelatin hydrolysate in spontaneously hypertensive rats

713

Angiotensin-I-converting enzyme (ACE)-inhibitory and antihypertensive properties of squid skin gelatin hydrolysates

714

Angiotensin-I-converting enzyme and prolyl endopeptidase inhibitory peptides from natural sources with a focus on marine processing by-products

715

Angiotensin-I-converting enzyme inhibitory activity and bitterness of enzymatically-produced hydrolysates of shrimp (Pandalopsis dispar) processing byproducts investigated by Taguchi design

716

Angiotensin-II activates apoptosis, proliferation and protein synthesis in the left heart ventricle of newborn albino rats

717

Angiotensin-II receptor antagonist losartan improves the exercise tolerance in patients with symptomatic congestive heart failure

718

Angiotensin-II type 1 receptor polymorphism is associated with an increased vasoreactivity to angiotensin II in human arteries

719

Angiotensin-II-receptor inhibitors in pregnancy

720

Angiotensin-II-receptor inhibitors in pregnancy

721

Angiotensin-II-receptor inhibitors in pregnancy

722

Angiotensinogen and angiotensin converting enzyme genotypes and carotid atherosclerosis: The atherosclerosis risk in communities and the NHLBI family heart studies Original Research Article

723

Angiotensinogen and endothelial nitric oxide synthase gene polymorphisms among Hispanic patients with preeclampsia

724

Angiotensinogen expression by rat epididymis: evidence for an intrinsic, angiotensin-generating system

725

Angiotensinogen Gene M235T and T174M Polymorphisms in Diabetic Nephropathy in a Bangladeshi Population

726

Angiotensinogen Gene M235T and T174M Polymorphisms in Essential Hypertension: Relation With Target Organ Damage

727

Angiotensinogen gene M235T polymorphism predicts left ventricular hypertrophy in endurance athletes

728

Angiotensinogen gene polymorphism in Japanese patients with hypertrophic cardiomyopathy

729

Angiotensinogen gene polymorphism is associated with insulin resistance in nondiabetic men with or without coronary heart disease, , ,

730

Angiotensinogen gene polymorphisms: relationship to blood pressure response to antihypertensive treatment: Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial

731

Angiotensinogen genotype affects HDL levels in afro-caribbeans

732

Angiotensinogen M235T polymorphism is associated with plasma angiotensinogen and cardiovascular disease, ,

733

Angiotensinogen Met235Thr polymorphism, angiotensin-converting enzyme inhibitor therapy, and the risk of nonfatal stroke or myocardial infarction in hypertensive patients

734

Angiotensinogen Promoter Sequence Variants in Essential Hypertension

735

Angiotensinogen T174M and M235T gene polymorphisms are associated with the extent of coronary atherosclerosis

736

Angiotensinogen Thr235 variant is associated with abnormal physiologic change of the uterine spiral arteries in first-trimester decidua, ,

737

Angiotensins differentially activate phospholipase d in vascular smooth muscle cells from spontaneously hypertensive and Wistar-Kyoto rats

738

Angiotension AT1Receptor Inhibition in Pacing Induced Heart Failure: Effects on Left Ventricular Myocardial Collagen Content and Composition

739

Angiotension-converting enzyme gene I/D polymorphism in patients with angina and normal coronary arteriograms

740

Angiotropic large B-cell lymphoma with clinical features resembling subacute combined degeneration of the cord

741

AngioVac System Used for Vegetation Debulking in a Patient with Tricuspid Valve Endocarditis: A Case Report and Review of the Literature

742

Angle amplification for nanoradian measurements

743

Angle and aspect dependent dew and fog precipitation in the Negev desert

744

Angle and Context Free Grammar Based Precarious Node Detection and Secure Data Transmission in MANETs

745

Angle- and gender-specific quadriceps femoris muscle recruitment and knee extensor torque

746

Angle and thickness dependence of magnetoresistance peaks in thin nickel films

747

ANGLE AND TIME OF ARRIVAL STATISTICS OF A THREE DIMENSIONAL GEOMETRICAL SCATTERING CHANNEL MODEL FOR INDOOR AND OUTDOOR PROPAGATION ENVIRONMENTS

748

ANGLE AND Z BEAMS IN BENDING: TENSOR MATRIX METHOD FOR SPREADSHEETS

749

ANGLE AND Z BEAMS IN BENDING: TENSOR MATRIX METHOD FOR SPREADSHEETS

750

Angle counts for isothetic polygons and polyhedra

751

Angle criteria for frame sequences and frames containing a Riesz basis

752

Angle decomposition of matrices Original Research Article

753

Angle dependence of intravascular ultrasound imaging and its feasibility in tissue characterization of human atherosclerotic tissue

754

Angle Dependence of Magnetic Oscillations in (TMTSF)2FSO3

755

Angle dependent condensing efficiency of Winston cone in terahertz region

756

Angle dependent laser nanopatterning of poly(ethylene terephthalate) surfaces

757

Angle dependent magnetoresistance oscillation study of the fermi surface of β″-(BEDT-TTF)2AuBr2

758

Angle dependent magnetoresistance oscillations of α-(BEDT-TTF)2KHg(SCN)4 under high pressure

759

Angle dependent magnetoresistance oscillations of β-(BEDT-TTP)2I3

760

Angle dependent X-ray photoemission study on UV-ozone treatments of indium tin oxide

761

Angle design of stator-rotor blades for VLH axial flow turbine using surrogate-based optimization

762

Angle distortion and conformality

763

Angle diversity and rate-adaptive transmission for indoor wireless optical communications

764

Angle estimation for two unresolved targets with monopulse radar

765

Angle Formed Between Patent Ductus Arteriosus and Descending Thoracic Aorta in a Beating Heart: A Helpful Study to Design a Better Device for Occluding Patent Ductus Arteriosus

766

Angle Kappa Measurements: Normal Values in Healthy Iranian Population Obtained With the Orbscan II

767

Angle of arrival estimation using spectral interferometry

768

Angle of Attack Investigations on the Performance of a Diverterless Supersonic Inlet

769

Angle of contact between sheet and die during stretch–bend deformation as determined on the bending-under-tension friction test system

770

Angle of incidence effects in a molecular solid

771

Angle of repose of landslide debris deposits induced by 2008 Sichuan Earthquake

772

Angle Optimization Algorithms For Five-Axis Milling Machines

773

Angle paradigm: A new method to measure right parietal dysfunctions in anorexia nervosa

774

775

Angle resolved imaging of polymer blend systems: From images to a 3D volume of material morphology

776

Angle Resolved Photoemission Spectroscopy of the InP 001/ surface

777

Angle resolved photoemission studies on Sm2−xCexCuO4: remnant Fermi surfaces and coupling to (π,π) scattering Original Research Article

778

Angle resolved photoemission study of image potential states and surface states on Cu(1 1 1)

779

Angle resolved photoemission study of quasi one-dimensional SrCuO2 by soft X-ray excitation

780

Angle resolved photoemission study of the Ce/Pd(1 1 1) interface

781

Angle resolved photoemission study of the spin-Peierls system α′-NaV2O5

782

Angle resolved ultraviolet photoelectron spectroscopy of oriented sexiphenyl layers

783

Angle resolved XPS of monomolecular layer of 5-chlorobenzotriazole on oxidized metallic surface

784

Angle resolved XPS studies on an anodic oxide formed on Ti–Nb–Sn alloy and the photo-induced change in carbon contaminants adsorbed on its surface

785

Angle resolved XPS study of inhomogeneous specimens of polycrystalline silver covered with uniform graphite overlayers

786

Angle resolved X-ray photoelectron spectroscopy study of Au deposited on Pt and Re surfaces

787

Angle resolved X-ray photoelectron spectroscopy study of Pd/NbOx/Nb interfaces

788

Angle strain and conjugation in conformations of heptafulvenes

789

ANGLE v2.1—New version of the computer code for semiconductor detector gamma-efficiency calculations

790

ANGLE v2.1—New version of the computer code for semiconductor detector gamma-efficiency calculations

791

Angle, energy and mass-resolved ion spectroscopy of core-excited polyatomic molecules

792

Angle, energy and mass-resolved ion spectroscopy of core-excited polyatomic molecules

793

Angle-, field-, temperature-, and size-dependent magnetic circular X-ray dichroism in Au/Co nanoclusters/Au(1 1 1)

794

ANGLE: An autonomous, normative and guidable agent with changing knowledge

795

Angle-adjustable sheath for a dual-stage venous cannula

796

Angle-Analyzer: A Triangle-Quad Mesh Codec

797

Angle-averaged effective proton–carbon analyzing powers at intermediate energies

798

Angle-averaged effective proton–carbon analyzing powers at intermediate energies

799

Angle-correlated spectrum measurement for two neutrons emitted from (n, 2n) reaction with the coincidence detection technique using a pencil-beam DT neutron source

800

Angle-correlated spectrum measurement for two neutrons emitted from (n, 2n) reaction with the coincidence detection technique using a pencil-beam DT neutron source

801

Angled abutments result in increased or decreased stress on surrounding bone of single-unit dental implants: A finite element analysis

802

Angle-dependence of the magnetotransport and Anderson localization in a pressure-induced organic superconductor

803

Angle-dependent cyclotron resonance in organic Q2D conductors

804

Angle-dependent infrared absorption spectroscopy at electrode/electrolyte interfaces

805

Angle-dependent light scattering in materials with controlled diffuse solar optical properties

806

Angle-dependent magnetoresistance oscillations and Fermi surface reordering at high magnetic fields in α-(ET)2KHg(SCN)4

807

Angle-dependent magneto-transport measurements on κ- (BEDT-TTF)2Cu(NCS)2 under pressure

808

Angle-dependent Mِssbauer study of the ground and second new metastable state in Na2[Fe(CN)5NO]·2H2O single crystals

809

Angle-dependent polariton collisional broadening in semiconductor microcavities

810

Angle-dependent switching of granular and multilayer perpendicular media

811

Angle-dependent ultraviolet photoelectron spectroscopy of sputter cleaned polycrystalline noble metals

812

Angle-dependent XPS analysis of silicon nitride film deposited on screen-printed crystalline silicon solar cell

813

Angle-dependent XPS study of functional group orientation for aminosilicone polymers adsorbed onto cellulose surfaces

814

Angle-dependent XPS study of the mechanisms of ‘‘high–low temperature’’ activation of GaAs photocathode

815

ANGLE-DIFFERENTIAL CROSS SECTIONS FOR RADIATIVE RECOMBINATION AND THE PHOTOELECTRIC EFFECT IN THE K, L, AND M SHELLS OF ONE-ELECTRON SYSTEMS CALCULATED WITHIN AN EXACT RELATIVISTIC DESCRIPTION

816

Angle-dispersive diffraction with synchrotron radiation at Laboratório Nacional de Luz Síncrotron (Brazil): potential for use in biomedical imaging

817

Angle-monotonicity of theta-graphs for points in convex position

818

Angle-resolved analysis of desorbed species in pulsed laser ablation on cadmium tungstate single crystal surfaces with different orientations studied by time-of-flight mass spectrometry

819

Angle-resolved and resonant photoemission study of the ZrO-like film on ZrC(1 0 0)

820

Angle-resolved characteristics of silicon photovoltaics with passivated conical-frustum nanostructures

821

Angle-resolved elastic peak electron spectroscopy: Role of surface excitations

822

Angle-resolved elastic-peak electron spectroscopy: Solid-state effects

823

Angle-resolved electron and ion spectroscopy apparatus on the soft X-ray photochemistry beamline BL27SU at SPring-8

824

Angle-resolved electron and ion spectroscopy apparatus on the soft X-ray photochemistry beamline BL27SU at SPring-8

825

Angle-resolved electron-electron and electron-ion coincidence spectroscopy: new tools for photoionization studies

826

Angle-resolved electron–electron and electron–ion coincidence spectroscopy: new tools for photoionization studies

827

Angle-resolved electronic decay of the π*, σ* and Rydberg resonances below the O K-edge in O2

828

Angle-resolved inverse photoemission of H-etched 6H-SiC (0001)

829

Angle-resolved inverse photoemission of the (2×1)-reconstructed 3C-SiC(0 0 1) surface

830

Angle-resolved inverse photoemission of the (2×1)-reconstructed 3C-SiC(0 0 1) surface

831

Angle-resolved ion yield spectroscopy for the 1s → 3π excited states in hot N2O molecules

832

Angle-resolved ion–electron coincidence experiments in molecular photoionization

833

Angle-resolved low-energy ion scattering studies of quasicrystalline Al–Pd–Mn

834

Angle-resolved measurements of product desorption and reaction dynamics on individual sites

835

Angle-resolved photoelectron spectroscopy of the satellite bands accompanying the O 1s mainline of CO2

836

Angle-resolved photoemission electron spectroscopy reveals a Fermi surface remnant with a d-wave like dispersion in the Mott insulator, Ca2CuO2Cl2

837

Angle-resolved photoemission from atomic-layer-resolved quantum well states in Ag/Fe(100)

838

Angle-resolved photoemission from stoichiometric GaN(0 0 0 1)-1 × 1

839

Angle-resolved photoemission measurements of omega-(n-pyrrolyl)alkanethiol self-assembled monolayers using in-situ sample preparation apparatus

840

Angle-resolved photoemission measurements of ω-(n-pyrrolyl)alkanethiol self-assembled monolayers using in-situ sample preparation apparatus

841

Angle-resolved photoemission spectroscopy measurements on (1 × 1) and (5 × 1) Pt(1 0 0)

842

Angle-resolved photoemission spectroscopy of band tails and anomalous kinetics of underdoped cuprates Original Research Article

843

Angle-resolved photoemission spectroscopy of SrCuO2: spin-charge separation?

844

Angle-resolved photoemission spectroscopy study of Fe(1 1 0) single crystal: Many-body interactions between quasi-particles at the Fermi level

845

Angle-resolved photoemission studies of the cuprate superconductors

846

Angle-resolved photoemission study for double Ag nano®lm structures

847

Angle-resolved photoemission study of Ag nanofilms grown on fcc transition-metal (111) substrates

848

Angle-resolved photoemission study of Co nanostructures on vicinal Au(1 1 1) surfaces

849

Angle-resolved photoemission study of CoSi2 nanofilms grown on Si(111) substrates

850

Angle-resolved photoemission study of Cu on ZnO(1 0 0); room temperature deposition and annealing effect

851

Angle-resolved photoemission study of Fe on a vicinal Au (7 8 8) surface

852

Angle-resolved photoemission study of quantized electronic structures on Ag nanofilms

853

Angle-resolved photoemission study of quasi one-dimensional conductor Nb3Te4

854

Angle-resolved photoemission study of the hydrogenated 3C-SiC(0 0 1)-2×1-H surface

855

Angle-resolved photoemission study of the surface electronic structure on NdB6 (110) clean surface

856

Angle-resolved photoemission study on the superconducting iron-pnictides of BaFe2(As,P)2 with low energy photons

857

Angle-resolved photofragmentation of the N K-shell excited CF3CN molecule

858

Angle-resolved spectator decay of vibrationally selected C 1s(2σ)−12π1 excited states in carbon monoxide

859

Angle-resolved study of hydrogen abstraction on Si(1 0 0) and Si(1 1 1): Evidence for non-activated pathways

860

Angle-resolved tunneling study on the anisotropic gap of Bi-2212 superconducting whisker

861

Angle-resolved ultraviolet photoelectron microspectroscopy

862

Angle-resolved ultraviolet photoelectron spectroscopy study on the α-Si(1 1 1)3×3-Bi surface

863

Angle-resolved UPS study and simulation with IAC approximation for oriented monolayer of tetratetracontane (n-C44H90) on Cu(100)

864

Angle-resolved XPS depth-profiling strategies

865

Angle-resolved XPS measurements on copper phthalocyanine thin films

866

Angle-resolved XPS studies on transition layers at SiO2/Si interfaces

867

Angle-resolved X-ray photoelectron spectroscopic study of the interface chemistry between ultra-thin aC overcoat and the magnetic layer on magnetic thin film disks

868

Angle-resolved X-ray photoelectron spectroscopic study of the interface chemistry between ultra-thin a-C overcoat and the magnetic layer on magnetic thin film disks

869

Angle-resolved X-ray photoelectron spectroscopy of topmost surface for LaNiO thin film grown on SrTiO substrate by laser 3 3 molecular beam epitaxy

870

Angle-resolved X-ray photoelectron spectroscopy study of the oxides on Nb surfaces for superconducting r.f. cavity applications

871

Angle-resolved-photoemission study of layer-structured nitride β-HfNCl

872

Anglersʹ perceptions of recreational fisheries and fisheries management in Mallorca

873

Angles between infinite dimensional subspaces with applications to the Rayleigh–Ritz and alternating projectors methods

874

Angles in Laguerre tessellation models for solid foams

875

Angle-scanned photoemission spectrum from Cu(1 0 0): theory vs experiment

876

Angle-scanned photoemission spectrum from Cu(1 0 0): theory vs experiment

877

Anglesite (PbSO4) leaching in citrate solutions

878

Anglesite flotation: a study for lead recovery from zinc leach residue

879

Angle-specific impairment of elbow flexors strength after isometric exercise at long muscle length

880

Angle-stable top-emitting white organic light-emitting devices employing a down-conversion layer

881

Angle-upported phakic intraocular lene followed by laer-aited in itu keratomileui for the correction of high myopia

882

Angle-velocity-resolved measurements of I(2P3/2,1/2) from (CH3I)n cluster photodissociation at 266 and 304 nm

883

Anglicism in the Translated Version of Headlines in Malay Printed Catalogues

884

Angling and recreation values of low-flow alleviation in rivers

885

Angling management organizations: integrating the recreational sector into fishery management

886

Anglo-American nursing theory, individualism and mental health care: a social conflict perspective

887

Anglo-American town planning theory since 1945: three significant developments but no paradigm shifts

888

Anglo-Saxon and German approaches to neoliberalism and environmental policy: The case of financing renewable energy

889

Anglo-Saxon and German life-cycle costing

890

Anglo-Saxon animal husbandry techniques revealed though isotope and chemical variations in cattle teeth

891

Anglo-Saxon Axis in 2003:Blairʹʹs Doctrine and Bush Invasion of Iraq

892

Angolan Cymbopogon citratus used for therapeutic benefits: Nutritional composition and influence of solvents in phytochemicals content and antioxidant activity of leaf extracts

893

Angolaʹs suffering behind a pretence of normality

894

Angor in a child: Left main coronary artery atresia

895

ANGPTL4 suppresses the profibrogenic functions of atrial fibroblasts induced by angiotensin II by up-regulating PPARγ

896

Angry and Aggressive Behavior Across Three Generations: A Prospective, Longitudinal Study of Parents and Children

897

Angry and Aggressive Behavior Across Three Generations: A Prospective, Longitudinal Study of Parents and Children

898

Angry Bird s Revenge: Hepatic Abscesses Secondary to Colonic Perforation

899

Angry memories and thoughts of revenge: The relationship between forgiveness and anger rumination

900

Angry men and disgusted women: An evolutionary approach to the influence of emotions on risk taking

901

Angry parents: a group psychotherapy manual for aggression management training

902

Angry? Letʹs talk about it!

903

ANGST OVER UNIVERSITY RANKINGS

904

Angstrom turbidity and ozone column estimations from spectral solar irradiance in a semi-desertic environment in Spain

905

Angstrom-beam electron diffraction of amorphous materials

906

Angstrom-Range Optical Path-Length Measurement with a High-Speed Scanning Heterodyne Optical Interferometer

907

Anguilla anguilla L. Biochemical and Genotoxic Responses to Benzo[a]pyrene

908

Anguilla anguilla L. genotoxic and liver biotransformation responses to abietic acid exposure

909

Anguilla anguilla L. liver EROD induction and genotoxic responses after retene exposure

910

Anguilla anguilla L. liver ethoxyresorufin O-deethylation, glutathione S-tranferase, erythrocytic nuclear abnormalities, and endocrine responses to naphthalene and β-naphthoflavone

911

Anguilla anguilla L. oxidative stress biomarkers responses to copper exposure with or without β-naphthoflavone pre-exposure

912

Anguilla anguilla L. oxidative stress biomarkers: An in situ study of freshwater wetland ecosystem (Pateira de Fermentelos, Portugal)

913

Anguilla anguillaL. Stress Biomarkers Recovery in Clean Water and Secondary-Treated Pulp Mill Effluent

914

Anguish over angiopathy: Hemolytic uremic syndrome

915

Anguishing Reports of Ambient Air Pollution in Tehran Capital of Iran

916

Angular (cis-stilbazole) geometry in octahedral dimethyldihalidoplatinum(IV) complexes: potential as metallomesogens and X-ray structure of [PtMe2I2(NC5H4CHCHC6H4OC7H15)2]

917

Angular analysis of bremsstrahlung in α-decay

918

Angular analysis of the muon pair asymmetry at LEP 1

919

Angular and energy analysis of HeH+ products from the charge exchange excitation reaction

920

Angular and energy dependences of the surface excitation parameter for electrons crossing a solid surface

921

Angular and energy dependences of the surface excitation parameter for semiconducting III–V compounds

922

Angular and fibrous particles in lung are markers of job categories

923

Angular and hyperangular momentum recoupling, harmonic superposition and Racah polynomials: a recursive algorithm

924

Angular and polarization dependence of Compton scattering from 4He in the Δ-resonance region

925

Angular and polarization effects in relativistic potential scattering of electrons in a powerful laser field

926

Angular and power characteristics of noncollinear acousto-optic tunable filters

927

Angular and radial geometries, charge transfer and binding strength in isolated complexes B⋯ICl: some generalisations

928

Angular and time resolution of neutron time of flight spectrometers

929

Angular and unrestricted limits of one-parameter semigroups in the unit disk

930

Angular and velocity distributions of desorbing molecules in steady-state NO+CO reaction on Pd(110)

931

Angular and velocity distributions of small cluster fragments in neutral (NH3)n scattering off LiF(100) Original Research Article

932

Angular anisotropy of products in the photodissociation of propene at 157 nm

933

Angular characterization of low concentrating PV–CPC using low-cost reflectors

934

Angular collection using solenoids

935

Angular collection using solenoids

936

Angular confinement and concentration in photovoltaic converters

937

Angular correlation of photons emitted from an excited quantum well

938

Angular correlation of ultra-high energy cosmic rays with compact radio-loud quasars

939

Angular correlations and statistical entropy of hard spherocylinders: the isotropic–nematic transition

940

Angular correlations in double ionization of Helium by high-energy Compton scattering

941

Angular correlations in double ionization of Helium by high-energy Compton scattering

942

Angular correlations of high momentum photons at 158 A GeV p+A and Pb+Pb collisions Original Research Article

943

Angular Deformities of the Lower Limb in Children

944

Angular dependence from L3-subshell to M-shell vacancy transfer probabilities for heavy elements using EDXRF technique

945

Angular dependence in photoemission: from atoms to surfaces to atoms

946

Angular dependence of dissociation in steering dominated activated reaction

947

Angular dependence of energy and particle fluxes in a magnetized plasma

948

Angular dependence of forward scattering induced by condensate on greenhouse cladding materials

949

Angular dependence of magnetic reversal in two-phased nanolayers

950

Angular dependence of magnetization reversal process in patterned Co thin films

951

Angular dependence of magnetoresistance in SDW state of (TMTSF)2PF6

952

Angular dependence of magnetoresistance of several Bechgaard salts

953

Angular dependence of particle correlations in pp collisions at 400 GeV/c

954

Angular dependence of particle correlations in π+K+p eractions at 250 GeV/c

955

Angular dependence of quartz fiber calorimeter response

956

Angular Dependence of Rayleigh-Wave Velocity in Prestressed Polycrystalline Media with Monoclinic Texture

957

Angular dependence of shot noise in the presence of Rashba spin–orbit coupling in semiconductor spintronics junctions

958

Angular dependence of the floating potential in a magnetized plasma

959

Angular dependence of the high field phase transition in α-(BEDT-TTF)2TlHg(SCN)4

960

Angular dependence of the magnetic-field driven superconductor–insulator transition in thin films of amorphous indium-oxide

961

Angular dependence of the magnetoresistance of TiSi2 single crystals

962

Angular dependence of the sputtering yield of water ice by 100 keV proton bombardment

963

Angular dependence of the two-electron intex distribution

964

Angular dependence of the unusual first-order transition temperature in single-crystal Gd/sub 5/(Si/sub ~0.5/Ge/sub ~0.5/)/sub 4/

965

Angular dependence of the wall correction factor for air kerma measurements using cylindrical cavity chambers

966

Angular dependence of vicinal carbon-proton coupling constants for conformational studies of the hydroxymethyl group in carbohydrates

967

Angular dependence of vortex matter phase transition in MgB2 single crystal Original Research Article

968

ANGULAR DEPENDENCE OF WAVE REFLECTION IN A LOSSY SINGLE-NEGATIVE BILAYER

969

Angular dependences in electroweak semi-inclusive leptoproduction Original Research Article

970

Angular dependences in inclusive two-hadron production at BELLE Original Research Article

971

Angular dependences of the switching field and coercivity for magnetic multilayer films with strain caused by lattice mismatch

972

Angular dependencies of exchange bias and coercivity in the ferromagnetic/antiferromagnetic bilayers not subjected to field-cooling treatments

973

Angular dependent magnetization studies of α-(BEDT-TTF)2KHg(SCN)4

974

Angular dependent magnetotransport and electronic structure in quasi-one-dimensional organic conductor (TMTSF)2ClO4

975

Angular dependent measurements of the ν=52 fractional quantum Hall effect state at ultra-low temperatures

976

Angular Derivatives of Holomorphic Maps in Infinite Dimensions

977

Angular dimensions of planetary nebulae

978

Angular dispersion of polar phonons in a hexagonal GaN–AlN superlattice

979

Angular displacement-enhanced heterodyne polarimeter for the measurement of optically active media

980

Angular distortion and through-thickness residual stress distribution in the friction-stir processed 6061-T6 aluminum alloy

981

Angular distribution and direct CP violation with perturbative strong phases in B → W decays

982

Angular distribution and polarization of photons in the inclusive decay Λb → Xsγ

983

Angular distribution anisotropy of fragments ejected from methyl iodide clusters: Dependence on fs laser intensity

984

ANGULAR DISTRIBUTION COEFFICIENTS FOR γ-RAY POLARIZATIONS PRODUCED IN POLARIZED CAPTURE REACTIONS

985

Angular distribution for the electron recoil in pair production by linearly polarized - rays on electrons

986

Angular distribution for the electron recoil in pair production by linearly polarized - rays on electrons

987

Angular distribution of Bremsstrahlung photons and of positrons for calculations of terrestrial gamma-ray flashes and positron beams

988

Angular distribution of Cherenkov light from electrons both produced and stopping in water

989

Angular distribution of Cherenkov light from electrons both produced and stopping in water

990

Angular distribution of coherent bremsstrahlung

991

Angular distribution of coherent bremsstrahlung

992

Angular distribution of decay leptons from e+e−→W+W− at threshold

993

Angular distribution of desorbing/permeating deuterium from modified Pd(1 1 1) surfaces

994

Angular distribution of Drell–Yan process at hadron colliders to NLO-QCD in models of TeV scale gravity Original Research Article

995

Angular distribution of ejected electrons from Ba 6pns (J=1) autoionizing states

996

Angular distribution of electrons elastically backscattered from amorphous overlayer systems

997

Angular Distribution of Gamma-Ray Bursts and Weak Lensing

998

Angular distribution of highly charged ions transmitted through metallic microcapillaries

999

Angular distribution of intensity of reflected radiation investigations of the influence of CO2 laser treatment on optical properties of hydrogenated amorphous silicon

1000

Angular distribution of leptons in general tt̄ production and decay

بازگشت